⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10615309 | 0.75 | — | — | |
| SCHEMBL8375403 | 0.73 | — | — | |
| SCHEMBL8372093 | 0.71 | — | — | |
| SCHEMBL16766198 | 0.71 | — | — | |
| SCHEMBL1887408 | 0.71 | — | — | |
| SCHEMBL23713463 | 0.71 | — | — | |
| SCHEMBL254131 | 0.71 | — | — | |
| SCHEMBL8035406 | 0.71 | — | — | |
| SCHEMBL13596749 | 0.71 | — | — | |
| SCHEMBL21862605 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765894-B2 | Norbornene-type polymers having quaternary ammonium functionality | PROMERUS, LLC (US) | 2014-07-01 | — | — | US | disclosed |
| US-8765893-B2 | Norbornene-type polymers having quaternary ammonium functionality | PROMERUS, LLC (US) | 2014-07-01 | — | — | US | disclosed |
| EP-2510036-A2 | NORBORNENE-TYPE POLYMERS HAVING QUATERNARY AMMONIUM FUNCTIONALITY | Promerus LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| US-20110244368-A1 | NORBORNENE-TYPE POLYMERS HAVING QUATERNARY AMMONIUM FUNCTIONALITY | PROMERUS LLC (US) | 2011-10-06 | — | — | US | disclosed |
| US-20110143260-A1 | NORBORNENE-TYPE POLYMERS HAVING QUATERNARY AMMONIUM FUNCTIONALITY | PROMERUS LLC (US) | 2011-06-16 | — | — | US | disclosed |
| WO-2011072304-A2 | NORBORNENE-TYPE POLYMERS HAVING QUATERNARY AMMONIUM FUNCTIONALITY | PROMERUS LLC (US) | 2011-06-16 | — | — | WO | disclosed |